1. Home
  2. PDYN vs ALLO Comparison

PDYN vs ALLO Comparison

Compare PDYN & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$7.45

Market Cap

291.5M

Sector

Industrials

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.55

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
ALLO
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.5M
252.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PDYN
ALLO
Price
$7.45
$2.55
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$8.00
$8.27
AVG Volume (30 Days)
2.0M
4.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
36.84
EPS
N/A
N/A
Revenue
N/A
$22,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$250.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.14
$0.86
52 Week High
$12.79
$2.80

Technical Indicators

Market Signals
Indicator
PDYN
ALLO
Relative Strength Index (RSI) 56.27 65.34
Support Level $6.87 $1.01
Resistance Level $7.89 N/A
Average True Range (ATR) 0.52 0.20
MACD 0.03 0.04
Stochastic Oscillator 86.27 79.03

Price Performance

Historical Comparison
PDYN
ALLO

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: